CHEMICALS AND DRUGS Chemical Actions and Uses [D27] Chemical Actions and Uses Pharmacologic Actions [D27.505] Pharmacologic Actions Molecular Mechanisms of Pharmacological Action [D27.505.519] Molecular Mechanisms of Pharmacological Action Enzyme Inhibitors [D27.505.519.389] Enzyme Inhibitors 5-Lipoxygenase-Activating Protein Inhibitors [D27.505.519.389.086] 5-Lipoxygenase-Activating Protein Inhibitors Acetaldehyde Dehydrogenase Inhibitors [D27.505.519.389.089] Acetaldehyde Dehydrogenase Inhibitors Adenosine Deaminase Inhibitors [D27.505.519.389.092] Adenosine Deaminase Inhibitors Adenylyl Cyclase Inhibitors [D27.505.519.389.108] Adenylyl Cyclase Inhibitors Aromatic Amino Acid Decarboxylase Inhibitors [D27.505.519.389.124] Aromatic Amino Acid Decarboxylase Inhibitors Calcineurin Inhibitors [D27.505.519.389.174] Calcineurin Inhibitors Carbonic Anhydrase Inhibitors [D27.505.519.389.200] Carbonic Anhydrase Inhibitors Catechol O-Methyltransferase Inhibitors [D27.505.519.389.237] Catechol O-Methyltransferase Inhibitors Cholinesterase Inhibitors [D27.505.519.389.275] Cholinesterase Inhibitors Cyclooxygenase Inhibitors [D27.505.519.389.310] Cyclooxygenase Inhibitors Gamma Secretase Inhibitors and Modulators [D27.505.519.389.315] Gamma Secretase Inhibitors and Modulators Glycoside Hydrolase Inhibitors [D27.505.519.389.320] Glycoside Hydrolase Inhibitors Cytochrome P-450 Enzyme Inhibitors [D27.505.519.389.335] Cytochrome P-450 Enzyme Inhibitors Folic Acid Antagonists [D27.505.519.389.350] Folic Acid Antagonists Histone Deacetylase Inhibitors [D27.505.519.389.360] Histone Deacetylase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors [D27.505.519.389.370] Hydroxymethylglutaryl-CoA Reductase Inhibitors Integrase Inhibitors [D27.505.519.389.375] Integrase Inhibitors beta-Lactamase Inhibitors [D27.505.519.389.400] beta-Lactamase Inhibitors Lipoxygenase Inhibitors [D27.505.519.389.480] Lipoxygenase Inhibitors Monoamine Oxidase Inhibitors [D27.505.519.389.616] Monoamine Oxidase Inhibitors Nucleic Acid Synthesis Inhibitors [D27.505.519.389.675] Nucleic Acid Synthesis Inhibitors Ornithine Decarboxylase Inhibitors [D27.505.519.389.705] Ornithine Decarboxylase Inhibitors Phosphodiesterase Inhibitors [D27.505.519.389.735] Phosphodiesterase Inhibitors Phosphoinositide-3 Kinase Inhibitors [D27.505.519.389.736] Phosphoinositide-3 Kinase Inhibitors Phospholipase A2 Inhibitors [D27.505.519.389.737] Phospholipase A2 Inhibitors Poly(ADP-ribose) Polymerase Inhibitors [D27.505.519.389.739] Poly(ADP-ribose) Polymerase Inhibitors Prolyl-Hydroxylase Inhibitors [D27.505.519.389.740] Prolyl-Hydroxylase Inhibitors Protease Inhibitors [D27.505.519.389.745] Protease Inhibitors Protein Kinase Inhibitors [D27.505.519.389.755] Protein Kinase Inhibitors Protein Synthesis Inhibitors [D27.505.519.389.760] Protein Synthesis Inhibitors Proton Pump Inhibitors [D27.505.519.389.848] Proton Pump Inhibitors Steroid Synthesis Inhibitors [D27.505.519.389.870] Steroid Synthesis Inhibitors Topoisomerase Inhibitors [D27.505.519.389.892] Topoisomerase Inhibitors Uncoupling Agents [D27.505.519.389.936] Uncoupling Agents

5-Lipoxygenase-Activating Protein Inhibitors - Preferred

Concept UI	M0545467
Scope note	Compounds that bind to and inhibit the action of 5-LIPOXYGENASE-ACTIVATING PROTEINS.
Preferred term	5-Lipoxygenase-Activating Protein Inhibitors
Entry term(s)	5 Lipoxygenase Activating Protein Inhibitors FLAP Inhibitors Inhibitors, 5-Lipoxygenase-Activating Protein Inhibitors, FLAP Protein Inhibitors, 5-Lipoxygenase-Activating